May. 14 at 10:11 AM
WATCHLIST MAY 14 2025
$ARTV Artiva Biotherapeutics Announces Longer-Term Phase 1/2 Data Demonstrating Prolonged Durability For AlloNK In Combination With Rituximab In Patients With B-cell-Non-Hodgkin Lymphoma At The ASGCT 28th Annual Meeting
$EXEL Invenra's Collaboration Partner Exelixis Initiates The Dose-Escalation Stage Of The First-In-Human Phase 1 Clinical Study Of XB628 In Participants With Recurrent Advanced Or Metastatic Solid Tumors
$OBIO Chardan Capital Maintains Buy on Orchestra BioMed Hldgs, Maintains
$20 Price Target
$RKLB Rocket Lab Completes Two Earth Return Missions in Two Months, Supports Varda Space's W-3 Capsule Recovery on May 14
$ECL Ecolab Life Sciences Has Officially Opened Its New Us Bioprocessing Applications Laboratory In King Of Prussia, Pennsylvania